Proteomic analysis of serum samples after cardiac arrest : Rationale and design of a TTM-trial substudy
(2025) In Resuscitation Plus 25.- Abstract
Background: A pilot study investigating proteomic profiles from 78 patients from the Target Temperature Management after Out-of-hospital Cardiac arrest (TTM) trial revealed 35 proteins associated to functional outcome, and six proteins associated to targeted temperature management at 33 °C. We present the protocol for a study investigating proteomic profiles in the full cohort of the TTM-trial biobank. The aim is to stratify protein profiles based on survival, functional outcome, targeted temperature management, and MIRACLE2 score in order to search for potential novel biomarkers. Methods: All patients with available serum samples at 24, 48, and/or 72 h after return of spontaneous circulation (N = 682 patients and N = 1882 samples) will... (More)
Background: A pilot study investigating proteomic profiles from 78 patients from the Target Temperature Management after Out-of-hospital Cardiac arrest (TTM) trial revealed 35 proteins associated to functional outcome, and six proteins associated to targeted temperature management at 33 °C. We present the protocol for a study investigating proteomic profiles in the full cohort of the TTM-trial biobank. The aim is to stratify protein profiles based on survival, functional outcome, targeted temperature management, and MIRACLE2 score in order to search for potential novel biomarkers. Methods: All patients with available serum samples at 24, 48, and/or 72 h after return of spontaneous circulation (N = 682 patients and N = 1882 samples) will be included in the liquid chromatography and tandem mass spectrometry analysis using diaPASEF, combining data-independent-acquisition of spectra with parallel accumulation-serial fragmentation. Statistical analysis will include data normalisation, exploratory principal component analysis, and differential expression analysis. Changes in serum protein abundance will be analysed according to survival and binary functional outcome (modified Rankin Scale 0–3 vs. 4–6) at six-months after randomisation, randomisation to target temperature of 33 °C or 36 °C, and the MIRACLE2 score. Secondary stratifications will include sex, age, time to return of spontaneous circulation, shockable vs. non-shockable initial rhythm, circulatory shock on admission, and presumed cause of death. Conclusion: This prospective study will provide information about proteomic profiles after cardiac arrest and may give insight for identification of novel biomarkers for prediction of outcome.
(Less)
- author
- Lileikyte, Gabriele
LU
; Bakochi, Anahita LU
; Isaksson, Marc LU ; Årman, Filip LU ; Moseby-Knappe, Marion LU ; Malmström, Johan LU
and Nielsen, Niklas LU
- organization
-
- Clinical Sciences, Helsingborg
- Infection Medicine Proteomics (research group)
- v1000000
- BioMS (research group)
- Neurological injury in acute type A aortic dissection (research group)
- Brain Injury After Cardiac Arrest (research group)
- LTH Profile Area: Engineering Health
- epIgG (research group)
- SEBRA Sepsis and Bacterial Resistance Alliance (research group)
- Center for cardiac arrest (research group)
- publishing date
- 2025-09
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Heart arrest, Hypothermic temperature control, Out-of-hospital cardiac arrest, Prognostication, Proteomics, Targeted temperature management
- in
- Resuscitation Plus
- volume
- 25
- article number
- 101014
- publisher
- Elsevier
- external identifiers
-
- scopus:105009749852
- ISSN
- 2666-5204
- DOI
- 10.1016/j.resplu.2025.101014
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © 2025 The Author(s)
- id
- 74d97190-6f8e-43e0-85ad-25b15a22f18a
- date added to LUP
- 2025-07-16 09:43:50
- date last changed
- 2025-07-17 16:06:50
@article{74d97190-6f8e-43e0-85ad-25b15a22f18a, abstract = {{<p>Background: A pilot study investigating proteomic profiles from 78 patients from the Target Temperature Management after Out-of-hospital Cardiac arrest (TTM) trial revealed 35 proteins associated to functional outcome, and six proteins associated to targeted temperature management at 33 °C. We present the protocol for a study investigating proteomic profiles in the full cohort of the TTM-trial biobank. The aim is to stratify protein profiles based on survival, functional outcome, targeted temperature management, and MIRACLE2 score in order to search for potential novel biomarkers. Methods: All patients with available serum samples at 24, 48, and/or 72 h after return of spontaneous circulation (N = 682 patients and N = 1882 samples) will be included in the liquid chromatography and tandem mass spectrometry analysis using diaPASEF, combining data-independent-acquisition of spectra with parallel accumulation-serial fragmentation. Statistical analysis will include data normalisation, exploratory principal component analysis, and differential expression analysis. Changes in serum protein abundance will be analysed according to survival and binary functional outcome (modified Rankin Scale 0–3 vs. 4–6) at six-months after randomisation, randomisation to target temperature of 33 °C or 36 °C, and the MIRACLE2 score. Secondary stratifications will include sex, age, time to return of spontaneous circulation, shockable vs. non-shockable initial rhythm, circulatory shock on admission, and presumed cause of death. Conclusion: This prospective study will provide information about proteomic profiles after cardiac arrest and may give insight for identification of novel biomarkers for prediction of outcome.</p>}}, author = {{Lileikyte, Gabriele and Bakochi, Anahita and Isaksson, Marc and Årman, Filip and Moseby-Knappe, Marion and Malmström, Johan and Nielsen, Niklas}}, issn = {{2666-5204}}, keywords = {{Heart arrest; Hypothermic temperature control; Out-of-hospital cardiac arrest; Prognostication; Proteomics; Targeted temperature management}}, language = {{eng}}, publisher = {{Elsevier}}, series = {{Resuscitation Plus}}, title = {{Proteomic analysis of serum samples after cardiac arrest : Rationale and design of a TTM-trial substudy}}, url = {{http://dx.doi.org/10.1016/j.resplu.2025.101014}}, doi = {{10.1016/j.resplu.2025.101014}}, volume = {{25}}, year = {{2025}}, }